Flynn Zito Capital Management’s Pfizer PFE Stock Holding History

Flynn Zito Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$230K	Sell	9,543 -132	-1%	-$3.45K	0.06%	146
2026 Q1	$272K	Buy	9,675 +219	+2%	+$5.83K	0.09%	114
2025 Q4	$235K	Buy	9,456 +214	+2%	+$5.4K	0.08%	119
2025 Q3	$235K	Buy	+9,242	New	+$228K	0.09%	124
2024 Q4	–	Sell	-7,158	Closed	-$207K	–	127
2024 Q3	$207K	Sell	7,158 -6,383	-47%	-$186K	0.1%	115
2024 Q2	$379K	Sell	13,541 -4,293	-24%	-$118K	0.19%	62
2024 Q1	$495K	Sell	17,834 -1,637	-8%	-$45.4K	0.26%	58
2023 Q4	$561K	Sell	19,471 -882	-4%	-$26.7K	0.38%	35
2023 Q3	$675K	Buy	20,353 +1,411	+7%	+$49.9K	0.47%	27
2023 Q2	$695K	Buy	18,942 +103	+0.5%	+$4.01K	0.47%	25
2023 Q1	$769K	Sell	18,839 -912	-5%	-$39.4K	0.56%	19
2022 Q4	$1.01M	Sell	19,751 -616	-3%	-$29.5K	0.85%	19
2022 Q3	$891K	Buy	+20,367	New	+$990K	0.88%	17
2022 Q2	–	Sell	-19,772	Closed	-$1.02M	–	102
2022 Q1	$1.02M	Buy	19,772 +9	+0%	+$467	0.87%	20
2021 Q4	$1.16M	Buy	+19,763	New	+$979K	0.99%	19

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Flynn Zito Capital Management's PFE Position: Q2 2026 in Review

Flynn Zito Capital Management reduced its Pfizer (PFE) stake by 1.4% in Q2 2026, selling an estimated $3.45K and leaving 9,543 shares worth $230K. The position accounts for 0.06% of the portfolio, ranked #146.

Flynn Zito Capital Management first reported a position in PFE in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.16M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Flynn Zito Capital Management held 9,543 shares of Pfizer worth $230K as of Q2 2026.
Flynn Zito Capital Management sold 132 Pfizer shares in Q2 2026, an estimated $3.45K.
Pfizer made up 0.06% of Flynn Zito Capital Management's portfolio in Q2 2026, its #146 holding.
Flynn Zito Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 15 quarters since.
Flynn Zito Capital Management's Pfizer position peaked at $1.16M in Q4 2021.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Flynn Zito Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.